OOIR: Observatory of International Research

Papers

(The median citation count of Current Rheumatology Reports is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Breaking Barriers: Essential Reforms for a Competitive and Affordable Biosimilars Market	41
Future of Low-Dose Computed Tomography and Dual-Energy Computed Tomography in Axial Spondyloarthritis	40
Decoding the Intricacies of Statin-Associated Muscle Symptoms	39
The Microbiome in Osteoarthritis: a Narrative Review of Recent Human and Animal Model Literature	34
Expert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of Response	34
Ectopic Nociceptor Sprouting as a Key Peripheral Driver of Pain in Rheumatoid Arthritis	33
Ultrasound Beyond Joints: A Review of Extra-Articular Applications in Rheumatology	32
AA Amyloidosis: A Contemporary View	31
Interstitial Pneumonia with Autoimmune Features: What the Rheumatologist Needs to Know	28
Deep Insight into the Role of MIF in Spondyloarthritis	26
Identification of Common Pathogenic Pathways Involved in Hemochromatosis Arthritis and Calcium Pyrophosphate Deposition Disease: a Review	25
Treatment of Persons with Rheumatoid Arthritis with a History of Cancer	25
Considerations for Pharmacologic Management of Rheumatoid Arthritis in the COVID-19 Era: a Narrative Review	25
Current perspective on infections and mitigation strategies in primary systemic vasculitis	24
Cardiac Manifestations in Behçet’s Syndrome	24
Exploring the Complex Relationship Between Microbiota and Systemic Lupus Erythematosus	23
How to Monitor Disease Activity of Axial Spondyloarthritis in Clinical Practice	23
Broadening the Scope of Resilience in Chronic Pain: Methods, Social Context, and Development	22
Unveiling the Potential of Probiotics in Osteoarthritis Management	20
Synovial Tissue Insights into Heterogeneity of Rheumatoid Arthritis	19
Classification Criteria for ANCA Associated Vasculitis – Ready for Prime Time?	19
MRI in the Diagnosis and Treatment Response Assessment of Chronic Nonbacterial Osteomyelitis in Children and Adolescents	18
Spectrum of Large- and Medium-Vessel Vasculitis in Adults: Neoplastic, Infectious, Drug-Induced, Autoinflammatory, and Primary Immunodeficiency Diseases	17
Flares in Lupus Nephritis: Risk Factors and Strategies for Their Prevention	17
Calcium Pyrophosphate Crystal Deposition: Insights to Risks Factors and Associated Conditions	16

Is There Still a Role of Plasma Exchange in the Current Management of ANCA-Associated Vasculitides?	16
Immune Checkpoint Inhibitor Associated Rheumatoid Arthritis	16
An Update on the Diagnosis and Management of Calcium Crystal Disease	16
Newer Autoantibodies and Laboratory Assessments in Myositis	16
Narrative Review: Peripheral Arterial Disease in Patients with Hyperuricemia and Gout	16
Air Pollution and Rheumatoid Arthritis Risk and Progression: Implications for the Mucosal Origins Hypothesis and Climate Change for RA Pathogenesis	15
Digital Approaches for Myositis	15
What can Animal Models tell us About T Cells in Spondyloarthritis Pathogenesis?	15
Spondyloarthritis Research and Treatment Network (SPARTAN) Clinical and Imaging Year in Review 2024	15
Digital Health and Self-Management in Idiopathic Inflammatory Myopathies: A Missed Opportunity?	14
Advances in Drug Research Targeting Neutrophils for the Treatment of Rheumatoid Arthritis	14
Anti- Melanoma Differentiation-Associated Gene 5 Antibody Positive Dermatomyositis: Recent Progress in Pathophysiology and Treatment	14
Keratinocytes – Amplifiers of Immune Responses in Systemic Lupus Erythematosus	13
Intravenous Immunoglobulin in Idiopathic Inflammatory Myopathies: a Practical Guide for Clinical Use	13
Calcium Pyrophosphate Crystal Formation and Deposition: Where Do we Stand and What Does the Future hold?	13
What to Know About Biopsy Sampling and Pathology in Vasculitis?	12
Spectrum of Spondyloarthritis Among Chinese Populations	12
Assessment of Physical Activity and Muscle Function in Adult Inflammatory Myopathies	12
Expanding Roles of Noncoding RNAs in the Pathogenesis of Systemic Lupus Erythematosus	12
How Has Molecular Biology Enhanced Our Undertaking of axSpA and Its Management	12
Neuroimmune Mechanisms Underlying Post-acute Sequelae of SARS-CoV-2 (PASC) Pain, Predictions from a Ligand-Receptor Interactome	12
An Update on Kawasaki Disease	11
Updating the 2019 ACR/SAA/SPARTAN Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis (SPARTAN 2024 Annual Meeting Proceedings)	11
Gaining Insight into Updated MR Imaging for Quantitative Assessment of Cartilage Injury in Knee Osteoarthritis	11
A Review of Difficult-to-Treat Rheumatoid Arthritis: Definition, Clinical Presentation, and Management	11
From Psoriasis to Psoriatic Arthritis: Ultrasound Insights Connecting Psoriasis with Subclinical Musculoskeletal Inflammation and the Path to Psoriatic Arthritis	11
Syndesmophyte Growth in Ankylosing Spondylitis: from Laboratory to Bedside	11
Oral Versus Subcutaneous Methotrexate in Immune-Mediated Inflammatory Disorders: an Update of the Current Literature	10
Cannabis for Rheumatic Disease Pain: a Review of Current Literature	10
Machine Learning Approaches to the Prediction of Osteoarthritis Phenotypes and Outcomes	10
Effect of Osteoporosis Treatments on Osteoarthritis Progression in Postmenopausal Women: A Review of the Literature	10
Role of IFN-α in Rheumatoid Arthritis	10
Year in Review in Axial Spondyloarthritis Clinical Research and Guidelines: SPARTAN 2023 Annual Meeting Proceedings	9
Do Disease-Modifying Anti-rheumatic Drugs and Exercise Therapy Have a Combined Effect on Disease Activity in Patients with RA? A Scoping Review	9
Recent Advances in the Immunopathology of Axial Spondyloarthritis: with and without HLA-B27	9
Paediatric Rheumatology Fails to Meet Current Benchmarks, a Call for Health Equity for Children Living with Juvenile Idiopathic Arthritis, Using Digital Health Technologies	9
Use of Imaging in Axial Spondyloarthritis for Diagnosis and Assessment of Disease Remission in the Year 2022	9
Gout, Hyperuricemia and Psoriatic Arthritis: An Evolving Conundrum	8
Year in Review: Novel Insights in the Pathogenesis of Spondyloarthritis – SPARTAN 2024 Annual Meeting Proceedings	8
Screening for Spondyloarthritis in Patients with Inflammatory Bowel Disease - SPARTAN 2024 Annual Meeting Proceedings	8
The Interplay of Biomechanical and Biological Changes Following Meniscus Injury	8
Systemic Lupus Erythematosus and COVID-19	7
Axial Spondyloarthritis and Diagnostic Challenges: Over-diagnosis, Misdiagnosis, and Under-diagnosis	7
Update on Cutaneous Signs to Assist in the Diagnosis of Dermatomyositis	7
Axial Spondyloarthritis in Japan	7
How to Use Janus Kinase Inhibitors in the Treatment of Rheumatoid Arthritis? A Clinical Assessment of Risks and Benefits	6
The Elusive Truth of Cannabinoids for Rheumatic Pain	6
Biorepositories For Global Rare Disease Research: A Narrative Review	6
Undifferentiated Connective Tissue Disease: Comprehensive Review	6
Correction to: Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis	6

Family Planning and Rheumatoid Arthritis	6
Spectrum of Large and Medium Vessel Vasculitis in Adults: Primary Vasculitides, Arthritides, Connective Tissue, and Fibroinflammatory Diseases	6
Neuromodulation as a Potential Disease-Modifying Therapy for Osteoarthritis	6
Correction: Family Planning and Rheumatoid Arthritis	6